24-Hour Intraocular Pressure Rhythm in Young Healthy Subjects Evaluated With Continuous Monitoring Using a Contact Lens Sensor
PUBLICATION - Jama Ophthalmologica - 24-Hour Intraocular Pressure Rhythm in Young Healthy Subjects Evaluated With Continuous Monitoring Using a Contact Lens Sensor
Benjamin Mottet, MSc; Florent Aptel, MD, PhD; Jean-Paul Romanet, MD; Ralitsa Hubanova,MD, MSc; Jean-Louis Pépin, MD, PhD; Christophe Chiquet, MD, PhD
JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2013.5297
Effect of overnight wear of Triggerfish sensor on corneal thickness measured by Visante anterior segment optical coherence tomography
PUBLICATION - Acta Ophthalmologica - CCT and corneal curvature irregularities increased slightly but significantly more in eyes with the Triggerfish CLS than in control eyes during overnight wear.
Ralitsa Hubanova, Florent Aptel, Christophe Chiquet, Benjamin Mottet, Jean-Paul Romanet
Acta Ophthamologica, DOI: 10.1111/aos.12241
Is 24-hour intraocular pressure monitoring necessary in glaucoma?
PUBLICATION - Seminars in Ophthalmology - Although intraocular pressure (IOP) is the only treatable risk factor for glaucoma, its 24-hour behavior is poorly understood.
Kaweh Mansouri, Robert N. Weinreb, and Felipe A. Medeiros
Seminars in Ophthalmology, 2013; 28(3): 157-164
Tolerability of 24-Hour Intraocular Pressure Monitoring of a Pressure-sensitive Contact Lens
PUBLICATION - Purpose: To investigate tolerability and safety of a new diagnostic device for 24-hour intraocular pressure monitoring in healthy subjects and age-matched glaucoma patients.
Katrin Lorenz, MD, FEBO, Christina Korb, MD, Nicola Herzog, MD, Jan M. Vetter, MD, FEBO, Heike Elflein, MD, Munir M. Keilani, MD, and Norbert Pfeiffer, MD - Journal of Glaucoma 2013, Apr-May;22(4):311-6 DOI: 10.1097/IJG.0b013e318241b874
A minimally invasive device for the monitoring of 24-hour intraocular pressure patterns
PUBLICATION - US Ophthalmic Review - Intraocular pressure (IOP) is the only modificable risk factor for glaucoma and lowering of IOP remains the mainstay of glaucoma treatment.
Kaweh Mansouri, MD, MPH, René Goedkoop, MD and Robert N Weinreb, MD
US Ophthalmic Review, 2013;6(1):10-4